Trilegal Advises API Holdings Ltd. In Relation To Competition Law Aspects Of Its Acquisition Of 66.1% Stake In Thyrocare Technologies Ltd.
The Trilegal competition team representing API was led by Nisha Kaur Uberoi, Partner & National Head – Competition Law; Harshita Parmar and Shambhvi Sinha, Senior Associates; and Akrathi Shetty and Rishi Kauntia, Associates.
Trilegal
Trilegal advised API Holdings Ltd. (“API”), the parent company of PharmEasy, in relation to the competition law aspects of its acquisition of 66.1% stake in Thyrocare Technologies Ltd. (“Thyrocare”).
This transaction marks the first time a unicorn is acquiring stake in a public listed company.
The Trilegal competition team representing API was led by Nisha Kaur Uberoi, Partner & National Head – Competition Law; Harshita Parmar and Shambhvi Sinha, Senior Associates; and Akrathi Shetty and Rishi Kauntia, Associates.
Other advisors:
AZB & Partners for M&A for API: Anand Shah and Pranav Atit.
Shardul Amarchand Mangaldas & Co for M&A for API.
Lead advisor: JM Financial for API.
Lead advisor on open offer: Kotak Investment Banking.
Shardul Amarchand Mangaldas & Co for Thyrocare: Raghubir Menon.
